AstraZeneca’s COVID therapy becomes first antibody approved for immunocompromised people preexposure
AstraZeneca’s COVID therapy becomes first antibody approved for immunocompromised people [...]
AstraZeneca’s COVID therapy becomes first antibody approved for immunocompromised people [...]
As end of New York opioid trial nears, AbbVie’s Allergan [...]
Shkreli’s former company Vyera settles for $40M in antitrust case, [...]
Former pharma CEO plundered millions from his own company, DOJ [...]
Novartis’ Sandoz yanks one lot of deep vein thrombosis injectable [...]
November sees Sanofi-Regeneron dethroned after 6-month rule over top TV [...]
Recordati to acquire EUSA Pharma for €750m, gaining 4 rare [...]
Bayer pads blockbuster case for Nubeqa with phase 3 win [...]
Fierce Pharma Asia—China’s insulin price cut; Astellas-Dyno gene therapy deal; [...]
BioNTech CEO Sahin urges calm amid omicron’s spread, figures new [...]